News & Updates

Show Multimedia Only

SGLT2 inhibitors potentially protective against dry eye disease

29 Sep 2022 by

Type 2 diabetes (T2D) patients on sodium-glucose cotransporter 2 (SGLT2) inhibitors appear to be at lower risk of dry eye disease (DED) compared with their counterparts who are receiving glucagonlike peptide-1 receptor agonists (GLP-1 RAs), as shown in a study.

29 Sep 2022

Low-, very low-dose bevacizumab for retinopathy of prematurity yield good outcomes

29 Sep 2022

Use of low- and very low-dose intravitreal bevacizumab (IVB) as initial treatment for type 1 retinopathy of prematurity (ROP) leads to satisfactory retinal structural outcomes, reports a study, noting that many eyes have received additional treatment.

29 Sep 2022

New ROTA imaging technique improves early diagnosis of glaucoma

29 Sep 2022 by

Researchers from the University of Hong Kong (HKU) and the Chinese University of Hong Kong (CUHK) have jointly developed an advanced imaging technique for retinal nerve fibre layer optical texture analysis (ROTA) that can improve the detection of early optic nerve damage in glaucoma.

29 Sep 2022

Vision impairment tied to depression, anxiety in children

28 Sep 2022 by

Children with vision impairment are at higher risk of developing symptoms of depression and anxiety, according to a study, noting that surgical treatment of strabismus may improve these symptoms.

28 Sep 2022

OFA unreliable at differentiating papilledema from pseudopapilledema in kids

12 Sep 2022

A recent study showed that oral fluorescein angiography (OFA) cannot definitively distinguish papilledema from pseudopapilledema in children, highlighting the need to interpret OFA findings in conjunction with other clinical findings.

12 Sep 2022

Regular coffee intake ups risk of primary open-angle glaucoma

06 Sep 2022 by

Genetic evidence from a recent study suggests that habitual coffee drinkers have an increased risk of primary open-angle glaucoma (POAG).

06 Sep 2022

Glaucoma risk modestly low in diabetes

04 Sep 2022

Patients with diabetes mellitus are at reduced risk of developing open-angle glaucoma (OAG), although the magnitude of reduction is modest, according to a study.

04 Sep 2022

Brolucizumab noninferior to aflibercept in nAMD

03 Sep 2022

Treatment with brolucizumab 6 mg, dosed every 4 weeks, is not inferior to aflibercept 2 mg, dosed every 4 weeks, in previously treated participants with neovascular age-related macular degeneration (nAMD) and persistent retinal fluid, a study has shown.

03 Sep 2022

Rapid macular thinning predicts hydroxychloroquine retinal toxicity

02 Sep 2022

In many patients receiving long-term hydroxychloroquine therapy, retinal thickness remains stable for years but may start to thin quickly after a critical point, according to a recent study.

02 Sep 2022

Serum lipids tied to intraocular pressure

02 Sep 2022

Serum total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) show a positive association with intraocular pressure (IOP), while triglyceride levels appear to have a negative association, reports a study.

02 Sep 2022

News & Updates

Showing Ophthalmology articles

Showing

Specialty:

SGLT2 inhibitors potentially protective against dry eye disease

Low-, very low-dose bevacizumab for retinopathy of prematurity yield good outcomes

New ROTA imaging technique improves early diagnosis of glaucoma

Vision impairment tied to depression, anxiety in children

OFA unreliable at differentiating papilledema from pseudopapilledema in kids

Regular coffee intake ups risk of primary open-angle glaucoma

Glaucoma risk modestly low in diabetes

Brolucizumab noninferior to aflibercept in nAMD

Rapid macular thinning predicts hydroxychloroquine retinal toxicity

Serum lipids tied to intraocular pressure